Feature

Building capacities for drug discovery in Latin America and the Caribbean

The COVID-19 pandemic highlighted the need for reducing regional dependency on external therapeutic drug supplies.

The hardest and costliest stage of drug development comes before the first trial. Pre-clinical development is a process in which molecules are prospectively tested for bioactivity and whether said molecule can exert a beneficial effect, for example, in the cure of a disease. 


This effort is made much easier by working in academic teams and using the latest technology to prospect for bioactivity among the metabolites of living organisms. The course Tools for the preclinical study of new bioactive molecules from a One Health perspective, held at Institut Pasteur from the 20th to the 26th of June 2025, was a great capacity-building and technology transfer experience that aims at achieving local autonomy in the field of drug development, thus reducing regional dependency. We thank Drs. Gloria López, Andrea Medeiros, and Beatriz Munguía for coordinating this activity, which will be a reference for the Global South.

group
lab

Suggested citation: "Building capacities for drug discovery in Latin America and the Caribbean," United Nations University, UNU-BIOLAC, 2025-08-02, https://unu.edu/biolac/feature/building-capacities-drug-discovery-latin-america-and-caribbean.

Related content

News

Next Course: “Synthetic Microbiology Symposium (SMS) 3.0: Whole-cell biosensors development ”, October 2025

Apply for a scholarship to participate in the course coordinated by Drs. Raul Platero and Vanessa Amarelle at IIBCE in Montevideo, Uruguay

30 Jul 2025

News

Next Course: “Innovative biotechnological approaches for biofilm control and characterization”, October 2025

Apply for a scholarship to participate in the course coordinated by Dr. Paola Scavone at IIBCE in Montevideo, Uruguay

29 Jul 2025

Blog Post

Harnessing Nature's Wisdom for Sustainable Development in the Global South

Venezuela guaranteed that all interests derived from its share in UNU-BIOLAC's Endowment Fund went entirely to the Programme, giving it adaptability

21 Jun 2025